The stock of Definitive Healthcare Corp. (NASDAQ:DH) increased by $0.01 on Friday to finish at $10.55, up 0.09 percent. The last five days have seen an average of 376,680 shares of common stock traded. 6 times new highs were reached in the current year, with a fall of -$0.44. The average number of shares traded over the last 20 days was 447,785, while the average volume over the last 50 days totaled 656,242.
DH stock dropped -9.13% since last month. On 08/11/23, the company’s shares reached a one-month low of $10.34. The stock touched a high of $24.29 on 02/02/23, after rallying from a low of $8.71 in 52 weeks. The price of DH stock has declined by -4.00% or -$0.44 this year, reaching a new high 6 times. Still, the stock price is down -56.57% from the 52-week high.
Insider Transactions
DH stock investors should be aware that Definitive Healthcare Corp. (DH) stock had its last reported insider trading activity 94 days ago on May 12. On May 12, Director SEA VII Management, LLC sold 6,240 shares at $9.11 each. This transaction resulted in the insider making $56,846. On Nov 07, Krantz Jason Ronald added 450,000 shares at a price of US$11.54. After the transaction, the insider now owns 450,000 shares.
Valuation Metrics
Beta for the stock is 0.72. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 7.02, the price-to-book (PB) ratio of 1.16, and the price-to-cash flow ratio of 58.13.
Financial Health
For the three months ended March 30, Definitive Healthcare Corp.’s quick ratio was 3.00, while its current ratio was 3.00, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending March 30 is 0.26, and the total debt to equity ratio is 0.27. As far as profitability goes, gross margin for the trailing twelve months is 81.40% percent. Definitive Healthcare Corp.’s EBITDA margin for the year ended March 30 was 10.57%, whereas its operating margin stood at -18.20% for the same period. Based on annual data, it had gross profit of $180.03 million and revenue of $222.65 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. DH’s return on assets (ROA) during the last 12 months has been -0.40%. There was a -2.00% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -1.00%.
Earnings Surprise
According to Definitive Healthcare Corp.’s quarterly financial report for the quarter that ended March 30, it had $252.47 million in total debt versus $218.96 million in cash and short-term investments. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $59.2 million, while revenues rose by 15.34% to $60.6 million. It was predicted that Definitive Healthcare Corp.’s quarterly earnings would be $0.06, but it ended up being $0.04. EBITDA was $4.15 million for the quarter. At the end of Definitive Healthcare Corp.’s most recent quarter ended March 30, its liabilities totaled 645.78 million, while its total debt was $273.91 million. Equity owned by shareholders amounts to $110.22 million.
Technical Picture
Here’s a quick look at Definitive Healthcare Corp.’s (DH) price momentum from a technical perspective. As of 11 August, the RSI 9-day stood at 35.09%, suggesting the stock is Neutral, with a 41.82% historical volatility rate.
The stochastic %K and %D were 6.45% and 17.45% respectively, while the average true range (ATR) was 0.55. Based on the 14-day stochastic reading of 10.57%, the RSI (14) reading is 40.95%. On the 9-day MACD Oscillator, the stock is at -0.44, and the 14-day reading is at -0.65.
Analyst Ratings
Definitive Healthcare Corp. (NASDAQ: DH) was downgraded by Robert W. Baird to a a Neutral rating in its latest research report. The stock was previously rated as a an Outperform. Analysts have assigned Definitive Healthcare Corp. (DH) an Overweight rating. DH is a stock that is recommended for selling by 0 brokerage firms, while 8 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 6 others recommend it as a buy.
What is DH’s price target for the next 12 months?
The current consensus forecast for the stock is between $10.00 and $17.00, with a median target price of $13.00. In analyzing these forecasts, the average price target given by analysts for Definitive Healthcare Corp. (DH) is $13.58.
